Home >> CAP TODAY Recommends >> IHC testing’s impact on skin cancer

IHC testing’s impact on skin cancer

image_pdfCreate PDF

May 18, 2016—A free webinar sponsored by Sigma-Aldrich will review the utility of immunohistochemical testing with markers such as S-100, SOX-10, Ber-Ep4, and HHV-8 in accurately diagnosing skin cancer and improving survival rates for patients with the disease. Register.

Continuing education credits for pathologists and histotechnologists attending this webinar will be offered through the National Society of Histotechnology. The speaker, Jeff Gordon, has more than 15 years of IHC diagnostic experience and conducted more than two dozen NSH-approved workshops.

CAP TODAY
X